Your shopping cart is currently empty

NLRP3-IN-24 (Compound 15a) is an inhibitor targeting NLRP3, effectively suppressing the activation of the NLRP3 inflammasome.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | NLRP3-IN-24 (Compound 15a) is an inhibitor targeting NLRP3, effectively suppressing the activation of the NLRP3 inflammasome. |
| In vitro | NLRP3-IN-24 (0.1-10 μM, 1 h) inhibits heme-induced NLRP3-mediated inflammatory responses in THP-1 cells and J774A.1 cells. Additionally, NLRP3-IN-24 (10 μM, 24 h) is non-toxic to J774A.1 cells. |
| In vivo | Administered as a single intraperitoneal injection of 10-30 mg/kg 30 minutes prior to LPS, NLRP3-IN-24 inhibits the activation of the NLRP3 inflammasome in a peritonitis model. |
| Formula | C19H26O3Si |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.